Clinical Trial Update: Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating the early effect of Vitamin D in primary hyperparathyroidism has been withdrawn. The study relates to hypercalcemia, os…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Hyperparathyroidism
• Osteopenia
• Osteoporosis
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Columbia University | Conditions: Primary Hyperparathyroidism, Hypercalcemia | Phase 2, Phase 3 | Status: WITHDRAWN